Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.

Many of the 61 million Americans with Medicare are wondering whether their out-of-pocket health costs will be higher in 2025 ...

Some important Medicare updates took effect on Jan. 1. One of the biggest changes is a $2,000 cap on out-of-pocket ...

The U.S. Centers for Medicare and Medicaid Services on Friday said it would not appeal a court order that it recalculate the ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

The General Enrollment Period provides an opportunity to make up for a past oversight — the failure to enroll in Part B.

As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

UnitedHealth (UNH) stock in focus as Medicare withdraws appeal over an unfavorable ruling related to the company's 2025-Star ...

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

UnitedHealth Group Inc. promoted the head of its Medicare health plan business to lead the company’s broader insurance ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...